Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements

Biometrical Journal

Volumn 45, Issue 8, 2003, Pages 931-945

  Alonso, Ariel ^a   Geys, Helena ^a   Molenberghs, Geert ^a   Kenward, Michael G ^b   Vangeneugden, Tony ^c  

^a HASSELT UNIVERSITY   (Belgium)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Bivariate longitudinal data; Canonical Correlations; Randomized Clinical Trials; Surrogate Marker; Validation

Indexed keywords

BIVARIATE; BIVARIATE LONGITUDINAL DATA; CANONICAL CORRELATIONS; INDIVIDUAL LEVELS; LONGITUDINAL DATA; RANDOMIZED CLINICAL TRIALS; REPEATED MEASUREMENTS; SURROGATE MARKER; UNIVARIATE; VALIDATION;

EID: 0347022252     PISSN: 03233847     EISSN: None     Source Type: Journal    
DOI: 10.1002/bimj.200390061     Document Type: Article

References (15)

1. ALBERT, A., IOANNIDIS, J. P. A., REICHELDEREER, P., CONWAY, B., COOMBS, R. W., CRANE, L., DEMASI, R., DIXON, D. O., FLANDRE, P., HUGHES, M. D., KALISH, L. A., LARNTZ, K., LIN, D., MARSCHNER, I. C., MUNOZ, A., MURRAY, J., NEATON, J., PETTINELLI, C., RIDA, W., TAYLOR, J. M. G., and WELLES, S. L., 1998: Statistical issues for HIV surrogate endpoints: point/counterpoint. Statistics in Medicine 17, 2435-2462.
2. BUYSE, M., MOLENBERGHS, G., BURZYKOWSKI, T., RENARD, D. and GEYS, H., 2000: The Validation of Surrogate Endpoints in Meta-analyses of Randomized Experiments. Biostatistics 1, 49-67.
3. CORTIÑAS ABRAHANTES, J., MOLENBERGHS, G., BURZYKOWSKI, T., SHKEDY, Z., ALONSO, A., and RENARD, D., 2003: Choice of units and modelling strategies in multilevel hierarchical models, with application to surrogate endpoint evaluation and complex surveys. Submitted for publication.
4. DANIELS, M. J. and HUGHES, M. D., 1998: Meta-analysis for the evaluation of potential surrogate markers. Statistics in Medicine 15, 1515-1527.
5. FREEDMAN, L., GRAUBARD, B., and SCHATZKIN, A., 1992: Statistical validation of intermediate endpoints for chronic diseases. Statistics in Medicine, 11, 167-178.
6. GAIL, M., PFEIFFER, R., VAN HOUWELINGEN, H. and CARROLL, R., 2000: On meta-analytic assessment of surrogate outcomes. Biostatistics, 1, 231-246.
7. GALECKI, A., 1994: General class of covariance structures for two or more repeated factors in longitudinal data analysis. Communications in Statistics: theory and methods 23, 3105-3119.
8. JORGENSEN, B., LUNDBYE-CHRISTENSEN, S., SONG, P. and SUN, L., 1999: A state space model for multi-variate longitudinal count data. Biometrika 86, 169-181.
9. LIN, D., FLEMING, T. and DE GRUTTOLA, V., 1997: Estimating the proportion of treatment effect explained by a surrogate marker. Statistics in Medicine 16, 1515-1527.
10. MOLENBERGHS, G., BUYSE, M., GEYS, H., RENARD, D., BURZYKOWSKI, T., and ALONSO, A., 2002: Statistical challenges in the evaluation of surrogate endpoints in randomized trials. Controlled Clinical Trials, 23, 607-625.
11. PRENTICE, R., 1989: Surrogate endpoints in clinical trials: definitions and operational criteria. Statistics in Medicine 8, 431-440.
12. SCHEMPER, M. and STARE, J., 1996: Explained Variation in Survival Analysis. Statistics in Medicine 1996, 1999-2012.
13. SY, J., TAYLOR, J. and CUMBERLAND, W., 1997: A stochastic model for the analysis of bivariate longitudinal AIDS data. Biometrics, 53, 542-555.
14. TIBALDI, F., CORTIÑAS ABRAHANTES, J., MOLENBERGHS, G., RENARD, D., BURZYKOWSKI, T., BUYSE, M., PARMAR, M., STIJNEN, T., and WOLFINGER, R., 2003: Simplified hierarchical linear models for the evaluation of surrogate endpoints. Journal of Statistical Computation and Simulation, (in press).
15. VERBYLA, A., CULLIS, B., KENWARD, M., and WELHAM, S., 1999: The analysis of designed experiments and longitudinal data by using smoothing splines. Appl. Statist., 48, 269-311.